Kopran Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2025.
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kopran Limited's Board met on August 8, 2025 to revisit the proposed merger of promoter group company Kopran Laboratories Limited (transferor) with Kopran Limited (transferee). This was a follow-up to the original March 20, 2025 announcement, after BSE and NSE asked the company to get fresh Board approval using updated financials and a new valuation. The Board reviewed a fresh valuation report from EY Merchant Banking Services, a fairness opinion from Saffron Capital Advisors, an auditor's certificate from Khandelwal Jain & Co., and three years of audited financials (FY23-FY25) plus Q1 FY26 results for both companies. After considering the Audit Committee and Independent Director committee reports, the Board concluded that no changes are required in the Scheme or the previously announced swap ratio, which stays the same.
This is a procedural step forward for the intra-group merger, and shareholders can take comfort that the deal terms remain unchanged. However, the merger is still subject to stock exchange (BSE/NSE) approval and NCLT clearance before it becomes effective, so no immediate impact on shareholding or stock price is expected from this update alone.